Nephrotic syndrome diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 26: | Line 26: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Medicine]] | |||
[[Category:Nephrology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Primary care]] | |||
[[Category:Emergency medicine]] | |||
Revision as of 00:41, 1 August 2018
|
Nephrotic Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nephrotic syndrome diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Nephrotic syndrome diagnostic study of choice |
|
Risk calculators and risk factors for Nephrotic syndrome diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Diagnostic study of choice for nephrotic syndrome is kidney biopsy that reveals the exact type of disease and the its progression.
Diagnostic Study of Choice
Study of choice
- Kidney biopsy is the gold standard test for the diagnosis of nephrotic syndrome.[1]
- This method will reveal the exact cause of proteinuria.
Relative contrandications of the kidney biopsy:
- Single kidney,
- Anatomic kidney abnormalities,
- Small size kidneys (less than 9 cm), indicative of end stage renal disease
- Renal tumor
- Multiple, bilateral cysts
- Active infection in the kidney or on the skin over the biopsy side
- Uncorrectable bleeding diathesis
- Severe uncontrolled hypertension
- Hydronephrosis
- Uncooperative patient